scanX
Home
J B Chemicals and Pharmaceuticals

J B Chemicals and Pharmaceuticals

1,664.35
-2.70
(-0.16%)
Market Cap (₹ Cr.)
₹25,874
52 Week High
2,030.00
Book Value
₹188
52 Week Low
1,371.00
PE Ratio
42.34
PB Ratio
8.05
PE for Sector
37.21
PB for Sector
3.95
ROE
18.90 %
ROCE
25.46 %
Dividend Yield
0.73 %
EPS
₹37.83
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
11.47 %
Net Income Growth
34.79 %
Cash Flow Change
27.97 %
ROE
14.36 %
ROCE
27.37 %
EBITDA Margin (Avg.)
18.76 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
259
299
303
287
323
325
316
284
319
293
357
310
330
367
412
368
394
423
446
401
420
512
420
556
516
559
546
538
585
717
742
732
702
858
844
807
825
957
965
Expenses
213
234
237
213
247
245
241
231
259
253
274
246
279
292
322
280
320
319
327
301
336
331
306
334
364
388
412
419
462
548
574
559
538
618
602
585
614
679
688
EBITDA
47
65
66
74
76
80
75
53
60
40
83
64
51
75
90
88
75
105
119
100
84
181
114
222
151
171
134
119
123
168
168
173
165
240
242
221
211
279
277
Operating Profit %
15 %
16 %
16 %
21 %
18 %
22 %
20 %
17 %
15 %
11 %
21 %
19 %
12 %
20 %
20 %
21 %
16 %
22 %
24 %
22 %
19 %
32 %
26 %
33 %
26 %
29 %
22 %
21 %
21 %
23 %
22 %
23 %
23 %
28 %
28 %
27 %
24 %
29 %
28 %
Depreciation
8
10
10
10
10
11
11
11
12
14
14
14
13
14
14
14
11
16
16
17
17
17
17
17
16
17
15
17
22
26
28
28
31
31
32
33
40
40
41
Interest
0
2
3
3
2
1
2
2
-0
1
1
1
1
1
1
1
1
1
1
1
0
4
2
1
1
1
1
1
2
6
8
9
12
11
9
12
8
4
2
Profit Before Tax
39
53
53
61
63
68
62
40
47
25
68
49
37
59
75
72
62
88
102
83
67
160
95
204
134
153
118
101
100
137
132
136
122
198
201
176
163
234
234
Tax
13
14
11
14
13
18
16
4
5
5
16
15
15
17
24
26
20
29
6
19
21
38
24
48
29
38
27
27
31
24
23
14
22
40
42
35
28
53
52
Net Profit
26
40
42
47
51
50
45
36
42
20
52
34
22
42
51
46
42
59
96
62
51
122
71
152
103
115
88
75
83
101
98
101
89
145
145
128
126
173
173
EPS in ₹
3.04
4.67
4.97
5.52
5.95
5.88
5.32
4.22
4.68
2.32
6.11
4.03
2.63
5.03
6.16
5.64
5.13
7.37
11.96
7.75
6.39
15.78
9.18
19.63
13.26
14.92
11.44
9.65
10.71
13.11
12.64
13.08
11.46
9.34
9.36
8.25
8.11
11.16
11.15
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,449
1,641
1,684
1,767
1,793
1,811
2,200
2,538
3,470
3,914
Fixed Assets
301
369
609
570
552
583
565
1,204
1,822
1,925
Current Assets
844
750
743
986
988
1,006
1,458
1,131
1,398
1,715
Capital Work in Progress
55
135
4
17
15
16
26
19
55
76
Investments
367
612
544
567
589
536
811
146
339
531
Other Assets
726
525
528
613
636
676
799
1,170
1,254
1,381
Total Liabilities
432
419
297
313
309
366
394
434
1,028
1,027
Current Liabilities
398
373
255
251
229
293
308
347
508
821
Non Current Liabilities
34
46
42
63
79
73
86
87
520
206
Total Equity
1,016
1,223
1,388
1,453
1,485
1,445
1,806
2,104
2,442
2,886
Reserve & Surplus
999
1,206
1,371
1,437
1,469
1,430
1,791
2,088
2,427
2,871
Share Capital
17
17
17
17
16
15
15
15
15
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-2
22
-30
32
9
-10
18
13
16
2
Investing Activities
-122
-52
-42
-24
-28
24
-231
4
-956
-412
Operating Activities
143
171
178
116
193
272
335
147
629
789
Financing Activities
-23
-97
-165
-59
-156
-305
-87
-138
343
-374
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
55.91 %
55.91 %
55.91 %
54.00 %
54.00 %
54.00 %
53.96 %
53.95 %
53.93 %
53.91 %
53.86 %
53.83 %
53.78 %
53.77 %
53.74 %
FIIs
7.54 %
8.37 %
8.74 %
9.12 %
9.22 %
8.85 %
8.66 %
8.80 %
8.63 %
9.54 %
10.05 %
10.35 %
11.05 %
12.17 %
13.61 %
DIIs
13.17 %
13.13 %
15.24 %
16.26 %
16.89 %
17.80 %
18.48 %
18.54 %
19.09 %
18.65 %
18.58 %
18.54 %
18.38 %
17.62 %
16.83 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.01 %
Public / Retail
23.38 %
22.58 %
20.12 %
20.62 %
19.89 %
19.35 %
18.91 %
18.71 %
18.36 %
17.91 %
17.51 %
17.28 %
16.78 %
16.43 %
15.81 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,768.25 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,459.20 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,551.10 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,177.55 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
935.50 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,016.00 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,228.50 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,552.50 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,467.20 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,560.15 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
30.17
ATR(14)
Less Volatile
59.53
STOCH(9,6)
Oversold
7.05
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-23.38
ADX(14)
Weak Trend
19.71
UO(9)
Bearish
32.39
ROC(12)
Downtrend And Accelerating
-11.45
WillR(14)
Oversold
-97.82
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.